Dānija - dāņu - SEGES Landbrug & Fødevarer

bayer a/s - glyphosat - vandopløseligt koncentrat - 360 g/l glyphosat

Dānija - dāņu - SEGES Landbrug & Fødevarer

de sangosse ltd. - uspecificeret - flydende middel - 0 g/l uspecificeret

Eiropas Savienība - dāņu - EMA (European Medicines Agency)

argenx - efgartigimod alfa - myasthenia gravis - immunosuppressiva - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Dānija - dāņu - SEGES Landbrug & Fødevarer

bayer a/s - glyphosat - vandopløseligt koncentrat - 480 g/l glyphosat

Dānija - dāņu - SEGES Landbrug & Fødevarer

bayer a/s - glyphosat - vandopløseligt granulat - 720 g/kg glyphosat

Dānija - dāņu - SEGES Landbrug & Fødevarer

bayer a/s - glyphosat - vandopløseligt koncentrat - 480 g/l glyphosat

Dānija - dāņu - SEGES Landbrug & Fødevarer

bayer a/s - glyphosat - vandopløseligt granulat - 720 g/kg glyphosat

Dānija - dāņu - SEGES Landbrug & Fødevarer

bayer a/s - glyphosat - vandopløseligt koncentrat - 360 g/l glyphosat

Eiropas Savienība - dāņu - EMA (European Medicines Agency)

ucb pharma sa - certolizumab pegol - crohnsygdom - immunosuppressiva - cimzia, in combination with methotrexate (mtx), is indicated for the treatment of moderate to severe, active rheumatoid arthritis (ra) in adult patients when the response to disease-modifying antirheumatic drugs (dmard) including methotrexate, has been inadequate. cimzia kan gives som monoterapi i tilfælde af intolerance overfor methotrexat eller når fortsatte behandling med methotrexat er upassende. cimzia has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function, when given in combination with methotrexate.

Eiropas Savienība - dāņu - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologiske - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).